3515 LYMAN BOULEVARD, CHASKA, MN
Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
Shareholder Director Nominations
Lifecore Biomedical, Inc. Adopts Incentive Bonus Plan for Executives
Investor Presentation
Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update
2025 Annual Meeting of Stockholders Held by Lifecore Biomedical, Inc.
Changes in Board, Management or Compensation
News, Letter Re Change in Certifying Accountant
Annual Report Transition
Q1
FY 2025
Q3
Q2
FY 2024
Notice of Late Filing for Annual Report
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload